IRCT20191217045767N1CompletedPhase 3
Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on lipid profile in STEMI patients
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •STEMI patients (for the first time) who receive Primary PCI within the first 6 hours
- •Age range 18 to 65 years
- •Consent to enter the research project and complete the informed consent form
Exclusion Criteria
- •Previous history of statin use
- •Patients with a previous history of cardiac surgery
- •Patients who subsequently undergo PCI have been nominated for CABG
Investigators
Similar Trials
Completed
Not Applicable
effect of high dose of atorvastatin after angioplasty in patients with stable anginastable angina.Chronic ischaemic heart diseaseIRCT2016060418741N2Mazandaran University of Medical Sciences469
Not yet recruiting
Phase 4
A clinical trial to compare the preventive effects of Atorvastatin and Rosuvasatin on kidney damage in patients undergoing cardiac surgeryCTRI/2023/08/056801Sreeja Nittoori
Completed
Phase 4
Study of effects of different doses of atorvastatin on lipid lowering in patients with high lipid levelsCTRI/2011/12/002216Jawaharlal Nehru Medical College300
Completed
Phase 3
Effect of high dose versus low dose Atorvastatin therapy on inflammatory & coagulatory factors in type 2 diabetic patientstype 2 diabetic.E10,E11,E1Diabetes mellitusIRCT201502226710N5Vice chancellor for research, Tabriz University of Medical Sciences Daneshgah Square Tabriz200
Recruiting
Phase 3
The effect of atorvastatin in the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapyIRCT20200825048515N36Esfahan University of Medical Sciences64